Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 9 April 2026Incoming appointee
2 itemsScheduled Appointment DateAfter approval at the 36th Annual General Meeting of Shareholders, scheduled for late May 2026
Ushio Shuro (牛尾 周朗)
Previous positionRepresentative Director and President of 株式会社メディカル･プリンシプル社 (current position)
New positionDirectors
入社年 2001
Yonehana Tetsuya (米花 哲也)
Previous positionAdvisor of 株式会社C&R EVERLASTING STORY (current position)
New positionOutside Director
入社年 Not disclosed
Departing officer
3 itemsDate of departureAt the conclusion of the Annual General Meeting of Shareholders, scheduled for late May 2026
Shimo Yoshio (下 義生)Next role stated
Former PositionDirectors
New positionRetirement
Sawada Hideo (澤田 秀雄)Next role stated
Former PositionOutside Director
New positionRetirement
Fujinobu Naomichi (藤延 直道)Next role stated
Former PositionOutside Director
New positionRetirement
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Will not remain on the Board of Directors
Directors after the change10Number
Shareholders’ meeting approvalRequired. Proposal for the election of director nominees at the 36th Annual General Meeting of Shareholders, scheduled for late May 2026
| Item | Details |
|---|---|
| Resolution date | 9 April 2026 |
| Scheduled Appointment Date | After approval at the 36th Annual General Meeting of Shareholders, scheduled for late May 2026 |
| Date of departure | At the conclusion of the Annual General Meeting of Shareholders, scheduled for late May 2026 |
| Name of appointee | Ushio Shuro (牛尾 周朗), Yonehana Tetsuya (米花 哲也) |
| Appointee's new position | Directors, Outside Director |
| Appointee's previous position | Representative Director and President of 株式会社メディカル･プリンシプル社 (current position), Advisor of 株式会社C&R EVERLASTING STORY (current position) |
| Year the appointee joined the Company | 2001, Not disclosed |
| Name of departing officer | Shimo Yoshio (下 義生), Sawada Hideo (澤田 秀雄), Fujinobu Naomichi (藤延 直道) |
| Former position of departing officer | Directors, Outside Director, Outside Director |
| New position of departing officer | Retirement, Retirement, Retirement |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors |
| Number of directors after the change | 10 directors (including 4 outside directors) |
| Subject to Approval by the General Meeting of Shareholders | Required. Proposal for the election of director nominees at the 36th Annual General Meeting of Shareholders, scheduled for late May 2026 |
Items this document does not state (8)
Appointee's date of birthNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No specific reason for the changes in directors is provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.